Take a trial of UK to unlock this pageFind out more

Relative Strength (%)
Volume Change (%)
10d v 3m
Price vs... (%)
52w High
50d MA
200d MA
Growth & Value
Margin of Safety (beta)
Screens Passed 1
Balance Sheet · Income Statement · Cashflow Financial Summary
Year End 31st Dec 2010 2011 2012 2013 2014 2015 2016E 2017E CAGR / Avg
Revenue $m
Operating Profit $m
Net Profit $m
EPS Reported $
EPS Normalised $
EPS Growth %
PE Ratio x
Operating Margin %
Op. Cashflow ps $
Capex ps $
Free Cashflow ps $
Last ex-div: 21st Apr, paid: 11th May more... Dividends
Dividend ps $
Dividend Growth %
Dividend Yield %
Dividend Cover x
Balance Sheet
Cash etc $m
Working Capital $m
Net Fixed Assets $m
Net Debt $m
Book Value $m
Average Shares m
Book Value ps $ +7.3%

FINANCIAL BRIEF: For the fiscal year ended 31 December 2015, Smith & Nephew plc revenues increased less than 1% to $4.63B. Net income decreased 18% to $410M. Revenues reflect market conditions. Net income was partially offset by Selling/General/Admin. Expense increase from $429M to $2.17B (expense), Legal and Other increase from $2M to $190M (expense), Amortisation of acquisition intangibles increase of 58% to $204M (expense). more »

Health Trend
Bankruptcy Risk
  Earnings Manipulation Risk
Magic Formula Score
Other Ratios
Leverage (ttm) Total Ex Intang
Gross Gearing %
Net Gearing %
Cash / Assets %
Recent History
Latest interim period (ended 31st Dec '15) vs. prior year
Sales Growth %
EPS Growth %
3yr Compound Annual Growth Rate
Sales Growth %
EPS Growth %
DPS Growth %

Broker Forecasts
31st Dec 2016
31st Dec 2017

Price Target: $18.3
(+19.71% above Price)
Net Profit EPS DPS Net Profit EPS DPS
Est. Long Term Growth Rate: +9.6% ($) (¢) (¢) ($) (¢) (¢)
Consensus Estimate
1m Change
3m Change
16 brokers Broker Consensus Trend
Broker Recommendations for Smith & Nephew
Recommendation:Strong SellSellHoldBuyStrong Buy
No. of Analysts: 0 0 11 4 6

Named Brokers and Analysts
Jefferies Chris Cooper , Credit Suisse Christoph Gretler , BERNSTEIN Lisa Bedell Clive , Investec Bank (UK) Plc Cora McCallum , Canaccord Genuity William Plovanic , Brean Capital, LLC Jason Wittes , Northland Securities Mark Landy , Nomura Securities , Panmure Gordon Savvas Neophytou , Numis Securities Sally Taylor , Edison Investment Research , Societe Generale Justin Smith , Berenberg Tom Jones , Shore Capital Stockbrokers Brian White , Morningstar, Inc. Debbie Wang , Day by Day Valérie GASTALDY , and 1 unnamed other

Profile Summary

Smith & Nephew plc is a global medical devices business operating in the markets for advanced surgical devices, which includes orthopedic reconstruction, trauma and sports medicine and advanced wound management. The Company operates in two segments: Advanced Surgical Devices and Advanced Wound Management. The Company's Advanced Surgical Devices (ASD) segment offers products and technologies, which include orthopedic reconstruction, trauma and extremities, sports medicine joint repair, arthroscopy enabling technologies and other advanced surgical devices (ASD). The Company's Advanced Wound Management (AWM) segment offers products, including Advanced Wound Care, Advanced Wound Devices and Advanced Wound Bioactives. The Company operates across the world and has distribution channels in over 100 countries.

Directors: Olivier Bohuon (CEO) 56, Julie Brown (CFO) 52, Rodrigo Bianchi (CEX) 55, Michael Frazzette (CEX) 53, R. Gordon Howe (CEX) 52, Diogo Moreira-Rato (CEX) 53, Glenn Warner (CEX) 52, John Campo (OTH) 60, Helen Maye (OTH) 55, Cyrille Petit (OTH) 44, Roberto Quarta (NEC) 64, Robin Freestone (NED) 56, Vinita Bali (NID) 59, Ian Barlow (NID) 63, Virginia Bottomley (NID) 67,

No. of Employees: 14,000 No. of Shareholders: n/a

Last Annual December 31st, 2015
Last Interim December 31st, 2015
Incorporated February 17, 1937
Public Since August 13, 1951
Shares in Issue 895,926,928
Free Float 890.2m (99.4%)

SN. Share Price Performance SN.Quote
11.0  1.0%
Traded 9:17am · Minimum 15 min delayed · NMS: 2.00k

Latest SN. News Announcements (delayed)

Upcoming SN. Events

Recent ↓
Thursday 30th July, 2015
Q2 2015 Smith & Nephew PLC Earnings Call
Thursday 30th July, 2015
Q2 2015 Smith & Nephew PLC Earnings Release
Thursday 30th April, 2015
Q1 2015 Smith & Nephew PLC Trading Statement Call
Thursday 30th April, 2015
Q1 2015 Smith & Nephew PLC Trading Statement Release
Wednesday 15th April, 2015
Dividend For SNN
Thursday 9th April, 2015
Smith & Nephew PLC Annual Shareholders Meeting
Wednesday 25th March, 2015
Smith & Nephew PLC Analyst & Investor Breakfast
Wednesday 25th March, 2015
Smith & Nephew PLC at Canaccord Genuity Musculoskeletal Conference
Thursday 5th February, 2015
Q4 2014 Smith & Nephew PLC Earnings Call
Thursday 5th February, 2015
Q4 2014 Smith & Nephew Earnings Release
Monday 12th January, 2015
Smith & Nephew PLC at JPMorgan Healthcare Conference (Q&A Session)
Monday 12th January, 2015
Smith & Nephew PLC at JPMorgan Healthcare Conference
Thursday 4th December, 2014
Smith & Nephew PLC at Berenberg European Conference
Tuesday 11th November, 2014
Smith & Nephew PLC Capital Markets Event
Thursday 30th October, 2014
Q3 2014 Smith & Nephew PLC Earnings Call
Thursday 30th October, 2014
Q3 2014 Smith & Nephew Earnings Release
Wednesday 22nd October, 2014
Dividend For SNN
Tuesday 14th October, 2014
Smith & Nephew PLC Split For SNN
Thursday 18th September, 2014
Smith & Nephew PLC at Bernstein Strategic Decisions Conference
Friday 1st August, 2014
Q2 2014 Smith & Nephew PLC Earnings Call

Use of our data service is subject to express Terms of Service. Please see our full site disclaimer for more details. In particular, it is very important to do your own research (DYOR) and seek professional advice before making any investment based on your own personal circumstances. Please note that the information, data and analysis contained within this stock report: (a) include the proprietary information of Stockopedia's third party licensors and Stockopedia; (b) should not be copied or redistributed except as specifically authorised; and (c) are not warranted to be complete, accurate or timely. You should independently research and verify any information that you find in this report. Stockopedia will not be liable in respect of any loss, trading or otherwise, that you may suffer arising out of such information or any reliance you may place upon it. Past performance is no guarantee of future results. The value and income derived from investments may go down as well as up. © Stockopedia 2016.

Should you buy SN.

Access SN. Analytics Now!

Let’s get you setup so you get the most out of our service
Done, Let's add some stocks
Brilliant - You've created a folio! Now let's add some stocks to it.

  • Apple (AAPL)

  • Shell (RDSA)

  • Twitter (TWTR)

  • Volkswagon AG (VOK)

  • McDonalds (MCD)

  • Vodafone (VOD)

  • Barratt Homes (BDEV)

  • Microsoft (MSFT)

  • Tesco (TSCO)
Save and show me my analysis